Study of risk factors and clinical management of patients with clinical non-response due to low plasma levels of anti-tubercular drugs
{{output}}
This study was carried out to assess the role of therapeutic drug monitoring of crucial first-line anti-tubercular drugs: rifampicin (R) and isoniazid (H) among 75 non-responding proven drug-sensitive tuberculosis patients on treatment followed by intervention... ...
